Evidence map›Paper›PMID 40735698›Full record

ReviewMaterials today. Bio2025

Nanotherapies based on bacterial metabolism: Mechanisms, design and application.

Jiaping Chen, Yanli Zhang, Xin Luo, Yuting Zeng, Ping Xiao, Xian Ding, Sijie Qiu, Qianlin Li, Qianwen Deng, Simin Wang and 4 more

Abstract readReview
In one paragraph

Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Targeting multidrug-resistantMaterials today. Bio · 2026
    Article
  4. Multifunctional FePharmaceutics · 2026
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jiaping ChenDepartment of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Yanli ZhangStomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, 510280, China.
Xin LuoDepartment of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Yuting ZengDepartment of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Ping XiaoDepartment of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Xian DingDepartment of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Sijie QiuDepartment of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Qianlin LiDepartment of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Qianwen DengDepartment of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Simin WangDepartment of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Ruofei LinDepartment of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Xiuwen ChenDepartment of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Dehong YangDepartment of Orthopedics - Spinal Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Wenjuan YanDepartment of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial metabolism provides the essential materials and energy for growth and reproduction. Through complex transformations and electron transfer, bacteria convert external nutrients into useable forms and achieve pathogenicity in the human body. In recent years, with the global spread of antibiotic resistance, traditional antibiotic treatments have become increasingly ineffective and may even exacerbate the imbalance of the human microbiota. As a novel type of antibacterial agent, nanomaterials possess superior characteristics when compared with traditional antibiotics. The most significant feature is their capacity to target multiple stages of bacterial metabolism, which endows them with substantial potential in the realm of antibacterial therapy. In the early stages of nutrient entry into bacterial metabolism, nanomaterials can not only induce oxidative stress imbalance and interrupt the transformation of metabolic substances, but also hinder the energy production process by disrupting the cell membrane or interfering with the operation of the electron transport chain. Moreover, through rational and meticulous design in terms of size, surface properties, solubility, and catalytic effects, nanomaterials can exhibit even more considerable antimicrobial potential. Therefore, this article, starting from the perspective of bacterial metabolism, provides a detailed discussion on the antimicrobial mechanisms, application background, and challenges and opportunities faced by nanomaterials, with the aim of guiding future research and promoting the further development of nanomaterials in the field of antimicrobial therapy.

Indexed as

Antimicrobial agentsBacterial metabolismDrug-resistant bacteriaElectron transport chainMetabolic regulationNanotherapyOxidative stress

Identifiers

PMID40735698
PMCPMC12305249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.